Goodwin advised ElevateBio on the financing. ElevateBio, LLC announced the closing of its $401 million Series D financing led by the AyurMaya Capital Management Fund, managed by...
ElevateBio’s $401 Million Series D Financing Round
Mercy BioAnalytics’ $41 Million Series A Financing
Goodwin advised Mercy BioAnalytics, Inc. on the deal. Mercy BioAnalytics, Inc. announced its $41 million Series A financing round. The financing was led by Novalis LifeSciences, with...
Berkshire Grey’s Merger Agreement with SoftBank Group
Goodwin advised Berkshire Grey, Inc. on the deal. Berkshire Grey, Inc. (Nasdaq: BGRY) announced its definitive merger agreement to be acquired by SoftBank Group Corp. and its...
Silver Lake and CPP Investments’ $12.5 Billion Acquisition of Qualtrics International
Goodwin Procter advised Qualtrics International Inc. on the deal. Qualtrics International Inc. (NASDAQ: XM) announced its definitive agreement to be acquired by Silver Lake, in partnership...
Sun Pharmaceutical’s $576 Million Acquisition of Concert Pharmaceuticals
Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an...
Onex’s Investment in Unanet
Goodwin Procter advised Unanet and JMI Equity on the deal, while Latham & Watkins represented Onex. Unanet announced a new round of strategic financing from Onex Corporation...
SonoThera’s $60.75 Million Series A Funding
Goodwin Procter advised SonoThera, Inc. on the deal. SonoThera, Inc. announced its $60.75 million Series A financing round to support the continued development of SonoThera’s ultrasound-guided, nonviral,...
Eric Goupil, GIC, IK Partners, Keensight and Parquest’s Acquisition of Unither Pharmaceuticals
Kirkland advised GIC, while Latham & Watkins advised Ardian on the deal. Arsene, Goodwin and Deloitte Société d’Avocats advised IK Partners, GIC, Keensight Capital and Parquest....
Naver Corporation’s Acquisition of Poshmark
Goodwin Procter advised Poshmark, Inc. on the deal, while Kirkland & Ellis advised Naver Corp. Poshmark, Inc. (Nasdaq: POSH) announced its definitive agreement to be acquired...
Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
Amazon.com’s $1.7 Billion Acquisition of iRobot Corporation
Goodwin Procter advised iRobot Corporation on the deal, while Paul, Weiss advised Amazon. iRobot Corporation (NASDAQ: IRBT) announced its definitive agreement to be acquired by Amazon.com, Inc....
CathWorks’ Acquisition Option Agreement and Co-promotion Agreement with Medtronic
Goodwin Procter advised CathWorks on the deal. CathWorks announced its acquisition option agreement and co-promotion agreement with Medtronic (NYSE: MDT). Under the acquisition option agreement, Medtronic will...




































